Omnia SanaPlant Comparison
Greater Celandine vs Black Cumin
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Greater Celandine and Black Cumin: they share 11 indicated uses (arthritis / joint pain, back pain, bloating, …); 4 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Greater Celandine | Black Cumin | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 5/10 | Stronger for Black Cumin |
| Back pain | 1/10 | 5/10 | Stronger for Black Cumin |
| Bloating | 1/10 | 5/10 | Stronger for Black Cumin |
| Cancer (anticancer research) | 2/10 | 7/10 | Stronger for Black Cumin |
| Headache | 1/10 | 5/10 | Stronger for Black Cumin |
| Indigestion | 1/10 | 5/10 | Stronger for Black Cumin |
| Infection (general) | 1/10 | 5/10 | Stronger for Black Cumin |
| Inflammation (general) | 1/10 | 5/10 | Stronger for Black Cumin |
| Pain (general) | 1/10 | 5/10 | Stronger for Black Cumin |
| Skin irritation | 1/10 | 5/10 | Stronger for Black Cumin |
| Wounds | 1/10 | 5/10 | Stronger for Black Cumin |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The biologically active and toxicologically important constituents.
The principal bioactive constituent of the seed oil, responsible for much of its anti-inflammatory, antioxidant and antimicrobial activity.
The aromatic fraction of the seed, contributing antimicrobial and antioxidant activity.
The bulk lipid fraction of the seed (roughly a third of seed weight by weight), the carrier for the fat-soluble thymoquinone.
Minor isoquinoline-type alkaloids studied for antioxidant activity.
Triterpene saponin studied for anticancer and antiparasitic activity.
Pharmacological Actions
Anti-inflammatory, antimicrobial and analgesic (preclinical)
Antispasmodic / choleretic bitter for upper-abdominal and biliary dyspepsia (indigestion, bloating, cramping) - oral use now restricted for safety
Antispasmodic / choleretic bitter for upper-abdominal and biliary dyspepsia (indigestion, bloating, cramping) - oral use now restricted for safety
Traditional & Indicated Uses
inferred from anti-inflammatory action
Antispasmodic / choleretic bitter for upper-abdominal and biliary dyspepsia (indigestion, bloating, cramping) - oral use now restricted for safety
inferred from anticancer action
Antispasmodic / choleretic bitter for upper-abdominal and biliary dyspepsia (indigestion, bloating, cramping) - oral use now restricted for safety
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from antispasmodic action
inferred from anti-inflammatory action
inferred from gastroprotective action
inferred from anti-inflammatory action
inferred from analgesic action
inferred from digestive action
inferred from antidiabetic action
inferred from anticancer action
inferred from immunomodulator action
inferred from analgesic action
inferred from digestive action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
SERIOUS: oral greater celandine can cause acute idiosyncratic liver injury (hepatocellular hepatotoxicity with jaundice). Multiple reported cases - dozens of herb-induced liver injury reports in the literature, with continuing recent case reports - led regulators to restrict or suspend oral products. Do not take internally if you have any liver disease, and stop immediately and seek care at any sign of liver problems (jaundice, dark urine, upper-abdominal pain).
Generally well-tolerated in clinical trials at doses up to 200 mg/day of oil for 90 days. Potential side effects may include mild gastrointestinal discomfort. Contraindicated during pregnancy due to potential uterine stimulant effects. May interact with immunosuppressants and antidiabetic medications. Allergic reactions possible in sensitive individuals. Consult healthcare provider before use, especially with concurrent medications.
Duke (2002) describes black cumin (Nigella sativa) as one of the most multi-active medicinal spices, with experimental evidence for bronchodilation, immunostimulation, hepatoprotection, and antihistaminic activity. The prophet Muhammad reportedly described it as 'a cure for all things except death.' Key bioactive compounds include thymoquinone and nigellone. Antihistaminic and bronchodilatory activity supports its traditional use in asthma and allergic conditions. Duke notes it is generally safe at culinary amounts but recommends caution with medicinal doses in pregnancy due to potential uterotonic effects (Duke, 2002).
External Ids
Botanical Description
Branching perennial herb with soft, brittle, hairy stems that exude a distinctive bright orange-yellow latex (sap) when cut or broken. The leaves are deeply lobed, pale bluish-green beneath, giving a delicate, almost fern-like appearance. Small, four-petalled, bright yellow flowers are borne in loose umbel-like clusters.[4]
Annual herb (Ranunculaceae), 20-90 cm tall, with an erect, branched stem and finely divided, pinnately dissected, fern-like leaves. Delicate pale blue-white (occasionally pale purple) flowers, each with 5-10 petal-like sepals, are surrounded by a feathery bract collar. The fruit is an inflated, many-celled capsule that dries and splits to release numerous small, black, angular seeds - the medicinal part.[1]
Habitat
Grows in shaded, nutrient-rich ground - hedgerows, walls, waste ground and woodland edges, often near old buildings; native to Europe and Western Asia and naturalised in North America.[4]
Native to the Mediterranean basin, southern Europe, western Asia and North Africa, and widely cultivated as a spice and medicinal crop across the Middle East, South Asia and North Africa; grows in cultivated fields and on disturbed ground.[1]
Harvesting
The flowering aerial parts are cut in spring to summer; the fresh orange latex is collected by breaking a stem or leaf as needed for topical (wart) use. Given the documented hepatotoxicity of oral preparations, harvesting for internal use is not recommended.[4]
Seed capsules are harvested once dried and brown (late summer), then threshed to release the small black seeds. Seed is stored whole and either used directly or cold-pressed for oil shortly before use to preserve the volatile thymoquinone-rich fraction.[1]
Traditional Uses
Greater celandine has a long European folk history, reflected in its name 'tetterwort', as a topical remedy for warts and skin blemishes (the fresh orange latex dabbed directly on), and internally as a bitter choleretic digestive remedy for biliary and upper-abdominal dyspepsia - though oral use is now medically restricted because of documented liver injury.[4]
One of the most celebrated medicinal seeds in Middle Eastern and Islamic traditional medicine - known as 'Habbatul Barakah' (the blessed seed) - black seed has traditionally been used for digestive complaints, respiratory conditions (asthma, cough), pain, inflammation, skin conditions and as a general tonic. Modern research on its principal constituent thymoquinone supports broad anti-inflammatory, antioxidant, antimicrobial, antidiabetic and immunomodulatory activity.[1, 2, 9]
Preparations
Fresh orange latex from a broken stem dabbed directly onto warts, the classic external folk use; kept well away from eyes, mucous membranes and broken skin.
Historically taken as an infusion or tincture for biliary dyspepsia, but oral use is now restricted in several jurisdictions due to hepatotoxicity risk and should only be considered under professional supervision, if at all.
Dosage
Because of a documented risk of acute liver injury, no internal dose is given here; oral use should be avoided, especially by anyone with liver disease, and any sign of jaundice, dark urine or upper-abdominal pain warrants immediate medical attention. Educational reference only, not a prescription.
References
Lookalikes Review
Drug Class Interactions
Not documented
References & Sources
- Li, X.L., Sun, Y.P., Wang, M., Wang, Z.B. and Kuang, H.X (2024) 'Alkaloids in Chelidonium majus L.: a review of its phytochemistry, pharmacology and toxicology', Frontiers in Pharmacology, 15, pp. 1440979. doi:10.3389/fphar.2024.1440979 Traditional / reference
https://doi.org/10.3389/fphar.2024.1440979 - Koriem, K.M.M., Arbid, M.S. and Asaad, G.F (2012) 'Chelidonium majus leaves methanol extract and its chelidonine alkaloid ingredient reduce cadmium-induced nephrotoxicity in rats', Journal of Natural Medicines, 67(1), pp. 159-167. doi:10.1007/s11418-012-0667-6 Preclinical
https://doi.org/10.1007/s11418-012-0667-6 - Nawrot, R (2017) 'Defense-related Proteins from Chelidonium majus L. as Important Components of its Latex', Current Protein & Peptide Science, 18(8), pp. 864-880. doi:10.2174/1389203718666170406124013 Traditional / reference
https://doi.org/10.2174/1389203718666170406124013 - Gilca, M., Gaman, L., Panait, E., Stoian, I. and Atanasiu, V (2010) 'Chelidonium majus - an integrative review: traditional knowledge versus modern findings', Forschende Komplementarmedizin. doi:10.1159/000321397 Traditional / reference
https://doi.org/10.1159/000321397 - Popovic, A., Deljanin, M., Popovic, S., Todorovic, D., Djurdjevic, P., Matic, S., Stankovic, M., Avramovic, D. and Baskic, D (2021) 'Chelidonium majus crude extract induces activation of peripheral blood mononuclear cells and enhances their cytotoxic effect toward HeLa cells', International Journal of Environmental Health Research, 32(7), pp. 1554-1566. doi:10.1080/09603123.2021.1897534 Preclinical
https://doi.org/10.1080/09603123.2021.1897534 - Shen, L., Lee, S.A., Joo, J.C., Hong, E., Cui, Z.Y., Jo, E., Park, S.J. and Jang, H.J (2022) 'Chelidonium majus induces apoptosis of human ovarian cancer cells via ATF3-mediated regulation of Foxo3a by Tip60', Journal of Microbiology and Biotechnology, 32(4), pp. 493-503. doi:10.4014/jmb.2109.09030 Preclinical
https://doi.org/10.4014/jmb.2109.09030 - Deljanin, M., Nikolic, M., Baskic, D., Todorovic, D., Djurdjevic, P., Zaric, M., Stankovic, M., Todorovic, M., Avramovic, D. and Popovic, S (2016) 'Chelidonium majus crude extract inhibits migration and induces cell cycle arrest and apoptosis in tumor cell lines', Journal of Ethnopharmacology, 190, pp. 362-371. doi:10.1016/j.jep.2016.06.056 Preclinical
https://doi.org/10.1016/j.jep.2016.06.056 - Warowicka, A., Qasem, B., Dera-Szymanowska, A., Wolun-Cholewa, M., Florczak, P., Horst, N., Napierala, M., Szymanowski, K., Popenda, L., Bartkowiak, G., Florek, E., Gozdzicka-Jozefiak, A. and Mlynarz, P (2021) 'Effect of protoberberine-rich fraction of Chelidonium majus L. on endometriosis regression', Pharmaceutics, 13(7), pp. 931. doi:10.3390/pharmaceutics13070931 Preclinical
https://doi.org/10.3390/pharmaceutics13070931 - Kadan, G., Gozler, T. and Hesse, M (1992) '(+)-Norchelidonine from Chelidonium majus', Planta Medica, 58(5), pp. 477. doi:10.1055/s-2006-961523 Preclinical
https://doi.org/10.1055/s-2006-961523 - Musidlak, O., Warowicka, A., Broniarczyk, J., Adamczyk, D., Gozdzicka-Jozefiak, A. and Nawrot, R (2022) 'The activity of Chelidonium majus L. latex and its components on HPV reveal insights into the antiviral molecular mechanism', International Journal of Molecular Sciences, 23(16), pp. 9241. doi:10.3390/ijms23169241 Preclinical
https://doi.org/10.3390/ijms23169241 - Zhang, W., You, C., Wang, C., Fan, L., Wang, Y., Su, Y., Deng, Z. and Du, S (2014) 'One new alkaloid from Chelidonium majus L', Natural Product Research, 28(21), pp. 1873-1878. doi:10.1080/14786419.2014.953497 Preclinical
https://doi.org/10.1080/14786419.2014.953497 - Capistrano I, R., Wouters, A., Lardon, F., Gravekamp, C., Apers, S. and Pieters, L (2015) 'In vitro and in vivo investigations on the antitumour activity of Chelidonium majus', Phytomedicine, 22(14), pp. 1279-1287. doi:10.1016/j.phymed.2015.10.013 Preclinical
https://doi.org/10.1016/j.phymed.2015.10.013 - Teschke, R., Frenzel, C., Glass, X., Schulze, J. and Eickhoff, A (2012) 'Greater Celandine hepatotoxicity: a clinical review', Annals of Hepatology. doi:10.1016/s1665-2681(19)31408-5 Clinical study
https://doi.org/10.1016/s1665-2681(19)31408-5 - Ciornolutchii, V., Ismaiel, A., Sabo, C.M., Al Hajjar, N., Seicean, A. and Dumitrascu, D.L (2024) 'A Hidden Cause of Hypertransaminasemia: Liver Toxicity Caused by Chelidonium Majus L. Report of Two Cases of Herb-Induced Liver Injury and Literature Review', American Journal of Therapeutics, 31(4), pp. e382--e387. doi:10.1097/MJT.0000000000001708 Clinical study
https://doi.org/10.1097/MJT.0000000000001708
- Hannan, M.A., Rahman, M.A., Sohag, A.A.M., Uddin, M.J., Dash, R., Sikder, M.H., Rahman, M.S., Timalsina, B., Munni, Y.A. and Sarker, P.P (2021) 'Black Cumin (Nigella sativa L.): A Comprehensive Review on Phytochemistry, Health Benefits, Molecular Pharmacology, and Safety', Nutrients, 13(6), pp. 1784. doi:10.3390/nu13061784 Meta-analysis / review
https://doi.org/10.3390/nu13061784 - Ahmad, A., Husain, A., Mujeeb, M., Khan, S.A., Najmi, A.K., Siddique, N.A., Damanhouri, Z.A. and Anwar, F (2013) 'A review on therapeutic potential of Nigella sativa: A miracle herb', Asian Pacific Journal of Tropical Biomedicine, 3(5), pp. 337-352. doi:10.1016/S2221-1691(13)60075-1 Meta-analysis / review
https://doi.org/10.1016/S2221-1691(13)60075-1 - Chatterjee, G., Saha, A.K., Khurshid, S. and Saha, A (2025) 'A Comprehensive Review of the Antioxidant, Antimicrobial, and Therapeutic Efficacies of Black Cumin (Nigella sativa L.) Seed Oil and Its Thymoquinone', Journal of Medicinal Food, 28(4), pp. 325-339. doi:10.1089/jmf.2024.k.0149 Meta-analysis / review
https://doi.org/10.1089/jmf.2024.k.0149 - Majdalawieh, A.F. and Fayyad, M.W (2015) 'Immunomodulatory and anti-inflammatory action of Nigella sativa and thymoquinone: A comprehensive review', International Immunopharmacology, 28(1), pp. 295-304. doi:10.1016/j.intimp.2015.06.023 Meta-analysis / review
https://doi.org/10.1016/j.intimp.2015.06.023 - Shaukat, A., Zaidi, A., Anwar, H. and Kizilbash, N (2023) 'Mechanism of the antidiabetic action of Nigella sativa and Thymoquinone: a review', Frontiers in Nutrition, 10, pp. 1126272. doi:10.3389/fnut.2023.1126272 Meta-analysis / review
https://doi.org/10.3389/fnut.2023.1126272 - Beheshti, F., Khazaei, M. and Hosseini, M (2016) 'Neuropharmacological effects of Nigella sativa', Avicenna Journal of Phytomedicine, 6(1), pp. 104-116. Meta-analysis / review
https://scholar.google.com/scholar?q=Neuropharmacological%20effects%20of%20Nigella%20sativa - Shafiq, H., Ahmad, A., Masud, T. and Kaleem, M (2014) 'Cardio-protective and anti-cancer therapeutic potential of Nigella sativa', Iranian Journal of Basic Medical Sciences, 17(12), pp. 967-979. Meta-analysis / review
https://scholar.google.com/scholar?q=Cardio-protective%20and%20anti-cancer%20therapeutic%20potential%20of%20Nigella%20sativa - Bordoni, L., Fedeli, D., Nasuti, C., Maggi, F., Papa, F., Wabitsch, M., De Caterina, R. and Gabbianelli, R (2019) 'Antioxidant and Anti-Inflammatory Properties of Nigella sativa Oil in Human Pre-Adipocytes', Antioxidants, 8(2), pp. 51. doi:10.3390/antiox8020051 Preclinical
https://doi.org/10.3390/antiox8020051 - Gholamnezhad, Z., Havakhah, S. and Boskabady, M.H (2016) 'Preclinical and clinical effects of Nigella sativa and its constituent, thymoquinone: A review', Journal of Ethnopharmacology, 190, pp. 372-386. doi:10.1016/j.jep.2016.06.061 Meta-analysis / review
https://doi.org/10.1016/j.jep.2016.06.061 - Ali, B.H. and Blunden, G (2003) 'Pharmacological and toxicological properties of Nigella sativa', Phytotherapy Research, 17(4), pp. 299-305. doi:10.1002/ptr.1309 Meta-analysis / review
https://doi.org/10.1002/ptr.1309 - Al-Attass, S.A., Zahran, F.M. and Turkistany, S.A (2016) 'Nigella sativa and its active constituent thymoquinone in oral health', Saudi Medical Journal, 37(3), pp. 235-244. doi:10.15537/smj.2016.3.13006 Meta-analysis / review
https://doi.org/10.15537/smj.2016.3.13006 - Ahmad A, Husain A, Mujeeb M, et al. A review on therapeutic potential of Nigella sativa: A miracle herb. Asian Pac J Trop Biomed. 2013;3 (2013) ';3(5):337-352', 3(5). Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC3642442/ Traditional / reference
https://pmc.ncbi.nlm.nih.gov/articles/PMC3642442/ - Darakhshan S, Bidmeshki Pour A, Hosseinzadeh Colagar A, Sisakhtnezhad S. Thymoquinone and its therapeutic potentials. Pharmacol Res. 2015;95-96:138-158. https://pmc.ncbi.nlm.nih.gov/articles/PMC4387230/ (2015) ';95-96:138-158'. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC4387230/ Traditional / reference
https://pmc.ncbi.nlm.nih.gov/articles/PMC4387230/ - Forouzanfar F, Bazzaz BSF, Hosseinzadeh H. A review of ethnobotany, phytochemistry, antimicrobial pharmacology and toxicology of Nigella sativa L. Biomed Pharmacother. 2021;142:112040. https://www.sciencedirect.com/science/article/pii/S0753332221009665 (2021) ';142:112040'. Available at: https://www.sciencedirect.com/science/article/pii/S0753332221009665 Traditional / reference
https://www.sciencedirect.com/science/article/pii/S0753332221009665 - Gholamnezhad Z, Keyhanmanesh R, Boskabady MH. Anti-inflammatory, antioxidant, and immunomodulatory aspects of Nigella sativa for its preventive and bronchodilatory effects on obstructive respiratory diseases. Biomed Pharmacother. 2021;136:111240. https://www.sciencedirect.com/science/article/pii/S0753332221002778 (2021) ';136:111240'. Available at: https://www.sciencedirect.com/science/article/pii/S0753332221002778 Traditional / reference
https://www.sciencedirect.com/science/article/pii/S0753332221002778 - Hannan MA, Rahman MA, Sohag AAM, et al. Black cumin (2021) ';13(6):1784', 13(6). doi:10.3389/fphar.2021.625386/full Randomized trial
https://doi.org/10.3389/fphar.2021.625386/full - Kooti W, Hasanzadeh-Noohi Z, Sharafi-Ahvazi N, et al. Phytochemistry, pharmacology, and therapeutic uses of black seed (2016) ';22(3):231-237', 22(3). Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC8225153/ Traditional / reference
https://pmc.ncbi.nlm.nih.gov/articles/PMC8225153/ - Tavakkoli A, Mahdian V, Razavi BM, Hosseinzadeh H. Review on clinical trials of black seed (2017) ';20(3):179-193', 20(3). Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC5633670/ Traditional / reference
https://pmc.ncbi.nlm.nih.gov/articles/PMC5633670/ - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Saadati, S., Naseri, K., Asbaghi, O., Abhari, K., Zhang, P., Li, H.B. and Gan, R.Y (2022) 'Nigella sativa supplementation improves cardiometabolic indicators in population with prediabetes and type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials', Frontiers in Nutrition, 9, pp. 977756. doi:10.3389/fnut.2022.977756 Meta-analysis / review
https://doi.org/10.3389/fnut.2022.977756 - Willcox, M.L., Elugbaju, C., Al-Anbaki, M., Lown, M. and Graz, B (2021) 'Effectiveness of Medicinal Plants for Glycaemic Control in Type 2 Diabetes: An Overview of Meta-Analyses of Clinical Trials', Frontiers in Pharmacology, 12, pp. 777561. doi:10.3389/fphar.2021.777561 Meta-analysis / review
https://doi.org/10.3389/fphar.2021.777561 - Daryabeygi-Khotbehsara, R., Golzarand, M., Ghaffari, M.P. and Djafarian, K (2017) 'Nigella sativa improves glucose homeostasis and serum lipids in type 2 diabetes: a systematic review and meta-analysis', Complementary Therapies in Medicine, 35, pp. 6-13. doi:10.1016/j.ctim.2017.08.016 Meta-analysis / review
https://doi.org/10.1016/j.ctim.2017.08.016 - Sahebkar, A., Soranna, D., Liu, X., Thomopoulos, C., Simental-Mendia, L.E., Derosa, G., Maffioli, P. and Parati, G (2016) 'A systematic review and meta-analysis of randomized controlled trials investigating the effects of supplementation with Nigella sativa (black seed) on blood pressure', Journal of Hypertension, 34(11), pp. 2127-2135. doi:10.1097/HJH.0000000000001049 Meta-analysis / review
https://doi.org/10.1097/HJH.0000000000001049 - Kavyani, Z., Musazadeh, V., Safaei, E., Mohammadi Asmaroud, M., Khashakichafi, F., Ahrabi, S.S. and Dehghan, P (2023) 'Antihypertensive effects of Nigella sativa supplementation: an updated systematic review and meta-analysis of randomized controlled trials', Phytotherapy Research, 37(8), pp. 3224-3238. doi:10.1002/ptr.7891 Meta-analysis / review
https://doi.org/10.1002/ptr.7891
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.